Gilson Gonçalves dos Santos

Gilson Gonçalves dos Santos

Auto-generated profile, based on publicly available information

Gilson Gonçalves dos Santos

Department of Anesthesiology, University of California, San Diego, CA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
GSGilson Gonçalves dos Santos
Gilson Gonçalves dos Santos
LDLauriane Delay
Lauriane Delay
TYTony L. Yaksh
Tony L. Yaksh
MCMaripat Corr
Maripat Corr
A high-intensity potentially tissue-injuring stimulus generates a homotopic response to escape the stimulus and is associated with an affective phenotype considered to represent pain. In the face of tissue or nerve injury, the afferent encoding systems display robust changes in the input–output function, leading to an ongoing sensation reported as painful and sensitization of the nociceptors such that an enhanced pain state is reported for a given somatic or visceral stimulus. Our understanding of the mechanisms underlying this non-linear processing of nociceptive stimuli has led to our appreciation of the role played by the functional interactions of neural and immune signaling systems in pain phenotypes. In pathological states, neural systems interact with the immune system through the actions of a variety of soluble mediators, including cytokines. Cytokines are recognized as important mediators of inflammatory and neuropathic pain, supporting system sensitization and the development of a persistent pathologic pain. Cytokines can induce a facilitation of nociceptive processing at all levels of the neuraxis including supraspinal centers where nociceptive input evokes an affective component of the pain state. We review here several key proinflammatory and anti-inflammatory cytokines/chemokines and explore their underlying actions at four levels of neuronal organization: (1) peripheral nociceptor termini; (2) dorsal root ganglia; (3) spinal cord; and (4) supraspinal areas. Thus, current thinking suggests that cytokines by this action throughout the neuraxis play key roles in the induction of pain and the maintenance of the facilitated states of pain behavior generated by tissue injury/inflammation and nerve injury.

10 March 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
AMAna M. Moreno
Ana M. Moreno
FAFernando Alemán
Fernando Alemán
GCGlaucilene F. Catroli
Glaucilene F. Catroli
MHMatthew Hunt
Matthew Hunt
MHMichael Hu
Michael Hu
PMPrashant Mali
Prashant Mali
In situ genome targeting of Na V 1.7 via CRISPRs and zinc fingers enables genomically scarless, durable, and nonaddictive management of pain.

10 May 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JNJuliana M. Navia-Pelaez
Juliana M. Navia-Pelaez
Soo-Ho ChoiSoo-Ho Choi
Soo-Ho Choi
LCLuciano Capettini
Luciano Capettini
YXYining Xia
Yining Xia
AGAyelet Gonen
Ayelet Gonen
YMYury I Miller
Yury I Miller
Neuroinflammation is a major component in the transition to and perpetuation of neuropathic pain states. Spinal neuroinflammation involves activation of TLR4, localized to enlarged, cholesterol-enriched lipid rafts, designated here as inflammarafts. Conditional deletion of cholesterol transporters ABCA1 and ABCG1 in microglia, leading to inflammaraft formation, induced tactile allodynia in naive mice. The apoA-I binding protein (AIBP) facilitated cholesterol depletion from inflammarafts and reversed neuropathic pain in a model of chemotherapy-induced peripheral neuropathy (CIPN) in wild-type mice, but AIBP failed to reverse allodynia in mice with ABCA1/ABCG1–deficient microglia, suggesting a cholesterol-dependent mechanism. An AIBP mutant lacking the TLR4-binding domain did not bind microglia or reverse CIPN allodynia. The long-lasting therapeutic effect of a single AIBP dose in CIPN was associated with anti-inflammatory and cholesterol metabolism reprogramming and reduced accumulation of lipid droplets in microglia. These results suggest a cholesterol-driven mechanism of regulation of neuropathic pain by controlling the TLR4 inflammarafts and gene expression program in microglia and blocking the perpetuation of neuroinflammation.

1 February 2019 in Neuroscience
Verified
Journal Article
Closed access
JTJuliana Maia Teixeira
Juliana Maia Teixeira
GSGilson Gonçalves dos Santos
Gilson Gonçalves dos Santos
ANAmanda Ferreira Neves
Amanda Ferreira Neves
MAMaria Carolina Pedro Athie
Maria Carolina Pedro Athie
IBIvan José Magayewski Bonet
Ivan José Magayewski Bonet
CPCarlos Amilcar Parada
Carlos Amilcar Parada

1 October 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GSGilson Gonçalves dos Santos
Gilson Gonçalves dos Santos
EDElayne Vieira Dias
Elayne Vieira Dias
JTJuliana Maia Teixeira
Juliana Maia Teixeira
MAMaria Carolina Pedro Athie
Maria Carolina Pedro Athie
IBIvan José Magayewski Bonet
Ivan José Magayewski Bonet
CPCarlos Amilcar Parada
Carlos Amilcar Parada

1 March 2017 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MOMaria Cláudia Gonçalves Oliveira-Fusaro
Maria Cláudia Gonçalves Oliveira-Fusaro
CZCristiane Isabel Silva Zanoni
Cristiane Isabel Silva Zanoni
GSGilson Gonçalves dos Santos
Gilson Gonçalves dos Santos
LMLuis Paulo Manzo
Luis Paulo Manzo
DADionéia Araldi
Dionéia Araldi
CPCarlos Amilcar Parada
Carlos Amilcar Parada